Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved ABRYSVO™ the company’s bivalent RSV prefusion F vaccine, for the prevention

MEI Pharma, Inc. today confirmed receipt of an unsolicited and non-binding proposal on May 23, 2023 from a group represented by Anson Advisors Inc. and Cable Car Capital LLC, as referenced

Aragen Life Sciences , a leading Contract Research and Development Organization, and FAR Biotech, a US-based, AI-driven, computational drug discovery company, have announced

Algiax Pharmaceuticals, today provided an update on its ongoing Phase 2a study with lead candidate AP-325 in patients with chronic neuropathic pain. As part of a planned mid-enrollment

ME Pharma N.V. a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment , announces the American Society of Clinical

Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceuticals SA,

Takeda Limited today announced that the U.S. Food and Drug Administration has granted priority review of the New Drug Application (NDA) for fruquintinib, a highly selective and potent inhibitor

TME Pharma NV a biotechnology company specializing in the development of novel therapies for the treatment of cancer by targeting the tumor microenvironment, announces that the American

AbCellera today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based

Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine treatments, has completed the redevelopment and expansion of its UK